Skip to main content
. 2017 Apr;5(7):160. doi: 10.21037/atm.2017.03.94

Figure 1.

Figure 1

Currently recognized subsets of DM as defined by having similar constellations of clinical, pathologic and serologic features. Anti-TIF1-λ, transcriptional intermediary factor-1 gamma autoantibody; Anti-MDA5, melanoma differentiation association protein 5 autoantibody.